Andrew S Iskandar

6PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 13, 2021
Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?

Constantin A Dasanu, Jaren Lerner, Miguel Michel Ocampo

|Sep 03, 2019
Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series.

Constantin A Dasanu, Andrew S Iskandar, Andrew Hwang

|Jun 27, 2019
Impact of therapeutic modalities on disease-specific survival in older adults with glioblastoma: A single-institution retrospective cohort study.

Andrew S Iskandar, Wesley T Kerr, Andrew Hwang

|Apr 04, 2019
Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series.

Andrew Hwang, Andrew S Iskandar, Wesley T Kerr

|Dec 22, 2018
Successful re-introduction of alectinib after inducing interstitial lung disease in a patient with lung cancer.

Andrew Hwang, Andrew Iskandar, Constantin A Dasanu

|Nov 30, 2018
Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximab.

Andrew Iskandar, Andrew Hwang, Constantin A Dasanu

Pageof 1